Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Ambrx Raises $23M Privately To Advance Growth Hormone

April 11, 2005

By Jennifer Boggs

BioMarin Pushes Phenoptin Into Pivotal Program In PKU

April 8, 2005

By Jennifer Boggs

Avanir Raises $17M, Continues Work On Neurodex Rolling NDA

April 8, 2005

By Jennifer Boggs

BioMarin Pushes Phenoptin Into Pivotal Program In PKU

April 8, 2005

By Jennifer Boggs

Avanir Raises $17M, Continues Work On Neurodex Rolling NDA

April 8, 2005

By Jennifer Boggs

License of cancer biomarker to Abbott a BioCurex 'major event'

April 7, 2005

By Jennifer Boggs

Geron, Exeter Form Joint Venture To Exploit Cloning IP From Roslin

April 7, 2005

By Jennifer Boggs

Geron, Exeter Form Joint Venture To Exploit Cloning IP From Roslin

April 7, 2005

By Jennifer Boggs

Lorus Bringing Antisense Drug To Collaboration With Sumitomo

April 6, 2005

By Jennifer Boggs

Lorus Bringing Antisense Drug To Collaboration With Sumitomo

April 6, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...